Alpha Tau Medical Ltd.
NASDAQ: DRTSW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Uzi Sofer
- Employees
- 117
- Headquarters
- Jerusalem, Israel
- IPO year
- 2026
- Market cap
- $1.2B
- Website
- https://www.alphatau.com
Loading DRTSW…
Loading profile data…Frequently asked questions about DRTSW
What does Alpha Tau Medical Ltd. (DRTSW) do?
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast...
Where does DRTSW trade?
Alpha Tau Medical Ltd. (DRTSW) trades on the NASDAQ.
What sector is DRTSW in?
Alpha Tau Medical Ltd. (DRTSW) operates in the Healthcare sector, specifically in the Medical - Specialties industry.
Who is the CEO of Alpha Tau Medical Ltd.?
Uzi Sofer is the chief executive officer of Alpha Tau Medical Ltd. (DRTSW).
Where is Alpha Tau Medical Ltd. headquartered?
Alpha Tau Medical Ltd. is headquartered in Israel.
Does DRTSW pay a dividend?
Alpha Tau Medical Ltd. (DRTSW) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did DRTSW go public?
Alpha Tau Medical Ltd. (DRTSW) completed its initial public offering in 2026.